FluoGuide Past Earnings Performance
Past criteria checks 0/6
FluoGuide's earnings have been declining at an average annual rate of -32%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 31.4% per year.
Key information
-32.0%
Earnings growth rate
-23.2%
EPS growth rate
| Biotechs Industry Growth | -14.6% |
| Revenue growth rate | 31.4% |
| Return on equity | -301.7% |
| Net Margin | -9,072.6% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How FluoGuide makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -38 | 44 | 0 |
| 30 Sep 23 | 0 | -37 | 39 | 0 |
| 30 Jun 23 | 0 | -34 | 38 | 0 |
| 31 Mar 23 | 3 | -33 | 39 | 0 |
| 31 Dec 22 | 7 | -27 | 39 | 0 |
| 30 Sep 22 | 8 | -25 | 36 | 0 |
| 30 Jun 22 | 16 | -26 | 40 | 0 |
| 31 Mar 22 | 13 | -24 | 40 | 0 |
| 31 Dec 21 | 10 | -24 | 38 | 0 |
| 30 Sep 21 | 8 | -22 | 36 | 0 |
| 30 Jun 21 | 0 | -17 | 29 | 0 |
| 31 Mar 21 | 0 | -18 | 27 | 0 |
| 31 Dec 20 | 0 | -17 | 25 | 0 |
| 30 Sep 20 | 0 | -14 | 12 | 0 |
| 30 Jun 20 | 0 | -16 | 11 | 0 |
| 31 Mar 20 | 0 | -12 | 11 | 0 |
| 31 Dec 19 | 0 | -10 | 11 | 0 |
Quality Earnings: 96X is currently unprofitable.
Growing Profit Margin: 96X is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 96X is unprofitable, and losses have increased over the past 5 years at a rate of 32% per year.
Accelerating Growth: Unable to compare 96X's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 96X is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: 96X has a negative Return on Equity (-301.71%), as it is currently unprofitable.